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Background: The aim of this study was to use transmission electron microscopy to describe the ultrastructural
characteristics of clots obtained from canine and feline platelet concentrates (PC) that had been activated with
calcium gluconate (CG) or CG plus batroxobin (CGB). Platelets from fibrin clots were classified according their
morphological changes. The area of the intercellular space (μm2), the area of the fibrin fibers (μm2), and the width
of the fibrin fibers (μm) were determined for the dog clots. The platelet area (μm2), the area of fibrin fibers (μm2),
the ratio of the minor and major axes of platelets, the ratio of the major and minor axes of platelets, and the
number of α-granules found within platelets were measured for the cat clots.
Results: Cat platelets displayed full activation. Dog platelets displayed lysis with loss of normal architecture. In both
species, a statistically significant difference was found (P < 0.01) between the fibrin fiber measurements in the PC
clots activated with CG and CGB.
Conclusions: The findings suggest that activation with CG caused platelet alpha granules to release their contents.
In cats, fibrin production was greater when the PC was activated with CG. In dogs, activation with CG produced
thick fibrin fibers.
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After a tissue injury, platelets adhere to the injured blood
vessels, which are in direct contact with the exposed colla-
gen in the extracellular matrix. This induces the release of
cytokines, growth factors and numerous pro-inflammatory
mediators, leading to platelet aggregation and the activa-
tion of intrinsic and extrinsic pathways of coagulation and
fibrin clot formation [1]. Cellular events that occur during
wound healing are initiated, maintained and mediated by a
complex series of biochemical events that start with the
release of cytokines and growth factors by platelets [2].
There is evidence that the proteins secreted by the
platelet α-granules not only produce hemostasis but* Correspondence: raul.silva@ucaldas.edu.co
1Departamento de Clinica e Cirurgia Veterinarias, Universidade Federal de
Minas Gerais, Belo Horizonte, Brasil
2Grupo de Investigación Terapia Regenerativa, Departamento de Salud
Animal, Universidad de Caldas, Caldas, Colombia
© 2013 Silva et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the oralso induce modulation of inflammation and wound
healing [3].
The use of blood-derived products to seal wounds and to
stimulate wound healing began with the use of fibrin glues
composed of concentrated fibrinogen (polymerization in-
duced by thrombin and calcium) and autologous fibrin
glues, which are considered the best choice for avoiding
viral infection [4]. Whitman et al. [5] described the use of
platelet concentrates to improve healing and to replace
fibrin glues. Autologous platelet concentrate (PC) prepara-
tions constitute a relatively new biotechnology in regenera-
tive medicine. They can be used for the modulation,
stimulation and acceleration of tissue healing and bone re-
generation in human beings [6,7] and horses [8,9].
Variations in some of the key properties of the PC,
including platelet concentration, the type of clot activa-
tor, and leukocyte content, can markedly influence thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Ultrastructural characteristics of fibrin clots from
feline platelet concentrates activated with calcium
gluconate or calcium gluconate plus batroxobin (the data
are presented as the mean (standard error))
Variable Calcium gluconate Calcium gluconate
plus batroxobin
Platelet area (μm2) 2.86 (0.24) a 3.79 (0.28)
Platelet area percentage (%) 12.34 (1.05) a 16.36 (1.20)
Ratio of minor-major axes 0.50 (0.03) a 0.60 (0.03)
Ratio of major-minor axes 2.28 (0.13) a 1.86 (0.01)
Area of fibrin fibers (μm2) 2.66 (0.17) a 1.58 (0.14)
Percentage area of fibrin
fibers (%)
11.50 (0.74) a 6.80 (0.58)
a, denotes statistically significant differences between rows by t-test (P < 0.01).
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supports the platelet and leukocyte concentrate during
its application. The density of the fibrin network is
mainly determined by the concentration of fibrinogen
during PC preparation [11]. Most protocols for PC prep-
aration result in low-density fibrin gels after activation.
These kinds of gels are convenient for surgical applica-
tions, but they lack a true fibrin support matrix. In
contrast, a high-density fibrin network means that the
platelet concentrate can be considered a biomaterial [4],
and the fibrin matrix itself might have potential healing
effects [12].
There is some information available on the electron
microscopy characteristics of platelet and fibrin net-
works in humans [13] and other animal species [14].
However, to our knowledge, there have been few studies
on the electron microscopy characteristics of platelet
and fibrin networks in clots of PC (in a platelet gel form)
from dogs and cats encountered in experimental and
clinical settings. This study describes the electron
microscopy characteristics of canine and feline PC acti-
vated with a non-proteic activating substance (calcium
gluconate, CG) or the combination of a proteic activating
substance (batroxobin) with calcium gluconate (CGB).
The aim of this study was to use transmission electron
microscopy to describe the ultrastructural characteristics
of clots (platelet gel) derived from PC collected by the
tube method [15,16] and activated with GC or GCB in
dogs and cats.
Results
The average hematological characteristics for dog whole
blood were as follows: platelet count 345300/μL, hematocrit
42.2%, white blood cell count (WBC) 16600/μL, lympho-
cytes 5050/μL, monocytes 790/μL, granulocytes 10700/μL,
mean platelet volume (MPV) 9.7 fL and platelet distribu-
tion width (PDW) 39.63%. Values for cat whole blood
were for platelet count of 412330/μL, hematocrit 33.86%,
WBC 10180/μL, lymphocytes 2950/μL, monocytes 630/μL,
granulocytes 6620/μL, MPV 7.60 fL and platelet distribu-
tion width 34.09%.
The average hematological characteristics for dog PC
were as follows: platelet count 529288/μL, hematocrit
4.70%, white blood cell count (WBC) 7391/μL, lympho-
cytes 3390/μL, monocytes 178/μL, granulocytes 3823/μL,
MPV 9.15 fL and PDW 37.60%. The average hematological
characteristics for cat PC were as follows: platelet count
863312/μL, hematocrit 1.48%, WBC 4280/μL, lymphocytes
2930/μL, monocytes 120/μL, granulocytes 1230/μL, MPV
9.30 fL and PDW 42.58%.
After activation and incubation, all of the canine plate-
lets displayed lysis and loss of their normal architecture,
which corresponds to type III in the classification of plate-
let morphological changes [17]. Platelet morphologicalchanges in cats included full activation in all platelets, an
irregular oval shape with centralization of organelles and
the extension of pseudopodia (type II) [17].
The samples from the cats showed a statistically
significant difference between the areas (μm2) or per-
centage areas of platelets and fibrin fibers, as well as the
ratios of the minor and major axis and the ratios of the
major and minor axes (Table 1, Figure 1). The median
number of α-granules of platelets activated with CG was
4.0 (interquartile range 1.0), and for platelets activated
with CGB the median was 8.0 (interquartile range 1.0).
These differences were statically significant (P < 0.05) by
the Wilcoxon test.
The samples from the dogs showed statistically signifi-
cant differences between CG and CGB activation (P < 0.01)
for the intercellular area (μm2), percentage of intercellular
space, fibrin fiber area (μm2), the percentage area of fibrin
fibers and the width of fibrin fibers in clots (Table 2,
Figures 2 and 3).
Discussion
The results of this study prevented a comparison between
the platelet gels (fibrin clots) obtained from the activated
PC of dogs and cats. The ultrastructural differences ob-
served within each species show that there are differences
in both platelet response and fibrin polymerization. In
addition, the platelets from cats and dogs are quite differ-
ent. The size of the cat platelets (diameter 2–6 mM, mean
platelet volume 8.6-14.1 fL) [18,19] differs from the size of
the dog platelets diameter (1–3 mM, mean platelet vol-
ume 8.4-11.5 fL) [20,21], and more complex factors such
as glycoprotein receptors and signal transduction path-
ways might be involved in the structural platelet responses
observed in our study [22].
According to Sweet et al. [23], platelet shape is ap-
proximately elliptical, and the ratio between the minor
and major axes is 0.5. Mody and King [24] thought that,
in general, the elliptical shape is determined by the ratio
Figure 1 Transmission electron micrograph showing the major and minor axes in cat platelets activated with calcium gluconate (A) or
calcium gluconate plus batroxobin (B). * Reference, major axes (continuous lines), minor axes (dotted lines). Arrows indicate fibrin.
Magnification is 18,000 X.
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but when this shape becomes more elongated, the ratio
is reversed so that the determination is being made by
the ratio between major and minor axes, which is always
>1 [24]. In our study, the platelets from cats activated
with calcium gluconate show a ratio between minor and
major axes of 0.5, and they show a ratio between major
and minor axes of 2.28. The cat platelets activated with
batroxobin show a ratio between minor and major axes
of 0.60 and a ratio between major and minor axes of
1.86, which puts them closer to the elliptical shape. This
suggests a greater change of the elliptical shape in plate-
lets activated with calcium gluconate.
Cat platelets activated with CGB occupied a greater
percentage of total area than platelets activated with CG,
and they also had a greater number of α-granules in
their cytoplasm. These findings, along with the relation-
ships between the axes, suggested a moderate degree of
platelet activation [23,24].
Platelet gel from dogs activated with CG presented
fibrin fiber widths of 209.4 nm and 172.6 nm. These
findings are within the range described for thick fibersTable 2 Ultrastructural characteristics of fibrin clots from
canine platelet concentrates activated with calcium
gluconate or calcium gluconate plus batroxobin (the data





Area of intercellular space (μm2) 4.44 (0.22) a 12.83 (0.33)
Percentage area of intercellular
space (%)
19.19 (0.95) a 55.41 (1.42)
Area of fibrin fibers (μm2) 4.44 (2.19) a 2.64 (1.53)
Percentage area of fibrin
fibers (%)
19.18 (9.45) a 11.45 (6.60)
Width of fibrin fibers (μm) 0.2094 (0.0297) a 0.1726 (0.0301)
a, denotes statistically significant differences between rows by t-test (P < 0.01).in horses (150–250 nm), human beings (203–441 nm),
monkeys (143–309 nm), oryxes (160–338 nm), sheep
(169–286 nm), penguins (182–391 nm) and sea turtles
(130–400 nm) [14]. However, Pretorius et al. used scan-
ning electron microscopy and did not provide informa-
tion about the ultrastructural characteristics of the
platelets contained in the PRP.
Pretorius et al. [14] also described the fine and inter-
mediate fibrin fibers for the aforementioned species.
However, these kinds of fibrin fibers were not observed
in our study. This may indicate that canine platelet gel
from PC activated with either CG or CGB produces only
fibrin fibers of higher quality compared with other spe-
cies (Pretorius et al. [14] used thrombin as an activating
substance). However, our results show that CGB pro-
duces thinner fibrin fibers than those from human PRP
activated with thrombin [14]. Our results clearly demon-
strate that the activating substance influences the quality
of the resulting biomaterial (biodrug).
The smaller area and percentage area of intercellular
space observed in the fibrin clots from canine PC acti-
vated with calcium gluconate suggest greater cell aggre-
gation. These findings, in conjunction with the greater
area and percentage of area of fibrin fibers and the
greater width of the fibrin fibers, indicate a strong de-
gree of platelet activation with rapid formation of fibrin
clots, and the fibers in these clots are thicker than those
from PC activated with CGB. It is important to consider
that platelet activation induced by CG is the result of
two different signaling events: the direct effect of Ca2+
on platelets [25] (after saturation of the calcium antag-
onist ACD) and the effect of autogenously generated
thrombin via Ca2+ dependent activation of the coagula-
tion pathway [26].
We are not aware of reports that describe the ultrastruc-
tural characteristics of platelet gels from dogs and cats,
but the general findings of this study indicate that, regard-
less of the substance used for PC activation, cat platelets
Figure 2 Transmission electron micrograph showing the characteristics of canine platelet gels activated with calcium gluconate (A) or
calcium gluconate plus batroxobin (B).← Platelet,→ Red blood cell, * intercellular space. Magnification is 4,800 X.
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reach the type IV morphological classification [17].
The differences observed between dog and cat clots
activated with either CG or CGB could depend on the
mechanisms of action of the two activating substances.
It is known that batroxobin does not activate platelets
trapped within the fibrin network [27]. In this study,
however, batroxobin was reconstituted with calcium
gluconate, and the amount of calcium was proportion-
ally less when PC was activated only with calcium gluco-
nate. The results observed in this study corroborate the
fact that, when batroxobin is used for PC activation,
there is no massive release of the contents of platelet
alpha granules, in contrast with the effect produced by
the calcium salts alone [28].
Conclusions
The findings of this study suggest that activation with
calcium gluconate produces a massive release of alphaFigure 3 Transmission electron micrograph showing the width of fibr
(A) or calcium gluconate plus batroxobin (B). * Reference, » Width of fibgranules, at least during the study period (2 hours of in-
cubation after activation). On the other hand, batroxobin
prevented early platelet degranulation [27]. Calcium glu-
conate also produced a better fibrin network than CGB
in both species.
The results of this study suggest that PC activated with
CG or CGB produces different rates of polymerization,
which could cause different speeds of incorporation of the
circulating cytokines into the fibrin meshes (intrinsic cyto-
kines). Therefore, the configuration of the fibrin mesh
implies differences in the lifespans of these cytokines [29].
This could mean that PC activated with CG produces a
thicker fibrin biomaterial and a faster release of GF and
cytokines and that PC activated with CGB produces a
slow release of growth factors (with a long-term effect).
Methods
The animal research ethics committee of the Federal
University of Minas Gerais approved this study.in fibers in clots of canine PC activated with calcium gluconate
rin fiber used for area measurement. Magnification is 18,000 X.
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Four mongrel male animals of each species were used
(dogs and cats), and all of the subjects were clinically
healthy at the time of blood collection.
Preparation of autologous platelet concentrates to obtain
a fibrin clot
Blood was collected by puncturing the jugular vein in the
cats and the saphenous vein in the dogs with a butterfly
catheter 21 G (Blood Collection Set, Becton Dickinson
and Company Vacutainer, New Jersey, USA). Blood sam-
ples were placed in an 8.5-mL tube with 1.5 mL ACD-A
(trisodium citrate 22 g/L, citric acid 8 g/L and dextrose
24.5 g/L) (Becton Dickinson and Company Vacutainer,
New Jersey, USA). To obtain PC, the feline blood samples
were centrifuged (Hettich Rotofix 32A, Tuttlingen,
Germany) at 85 g, and the canine blood samples were
spun at 191 g for 6 minutes (SIGMA 3 K30, Germany).
Activation of platelet concentrates
Before activation, PC samples were analyzed using an
automated counting device by volumetric impedance
(Abacus Junior Vet, Austria). Each sample was analyzed
in triplicate. Next, a micropipette with a fixed volume of
1000 μL was used to collect (approximately) the first 100
μL of the red portion and the first 900 μL of plasma
below and above the blood-plasma interface, respect-
ively. Samples of each species were divided into two ali-
quots of 500 μL each, thus forming two groups. The PC
samples from one group were activated with 50 μL of
calcium gluconate 10% (Ropsohn Therapeutics Ltda,
Bogotá, Colombia), and the samples of the other group
were activated with 50 μL of batroxobin (Plateltex,
Praha, Czech Republic) and reconstituted with 1 mL of
calcium gluconate 10%.Fibrin clot (platelet gel) preparation for transmission
electron microscopy
Two hours after activation, the supernatant was re-
moved from each sample, and the clots were fixed
with a “Karnovsky - modified” primary solution (equal
parts glutaraldehyde 2.5% and paraformaldehyde 2%)
and post-fixed with osmium tetroxide 2% buffered.
Subsequently, the fibrin clots were dehydrated in suc-
cessive passes of 15 minutes in ethanol at concentra-
tions of 50%, 70% (2 times), 85% (2 times), 95%
(2 times), and 100% (three times). Finally, they were
placed in acetone for 15 minutes (2 times). The fibrin
clots were embedded in resin-acetone (1:2) for 1 hour,
resin-acetone (1:1) for 1 hour, resin-acetone (2:1) for
12 hours at room temperature, and pure resin for 1 hour,
followed by incorporation into molds and storage in a
40°C oven for 1 hour and a 60°C oven for 48 hours. Thepolymerized samples were used to obtain ultrathin
sections of approximately 60 nm, taken once every
300 nm (approximately). The samples were stained
for contrast with uranyl acetate and lead citrate. The
plates were viewed on a transmission electron micro-
scope (Tecnai G2 Spirit - FEI - 2006, 120 kV). One
plate of each sample was evaluated on the transmis-
sion electron microscope.Evaluation of the micrographs
Microscopic analysis of the 25 micrographs was
performed for each plate by taking 100 photomicro-
graphs for each activating substance for each species
(200 total for each species). Morphological changes in
the platelets of the fibrin clots were initially scored for
both species using a scale from 0 to III [17], where 0:
unstimulated platelet, slightly oval-shaped, with evenly
dispersed organelles in the cytoplasm; I: platelet in
uncertain state, rounded profile shape, non-centralized
organelles; II: Platelet fully activated, irregular oval with
centralization of organelles and extension of pseudopo-
dia; III: damaged platelet, with total lysis and loss of
normal architecture.
In addition to the initial classification used for both
species, some platelet and fibrin characteristics were in-
dependently analyzed for each species. The parameters
considered in cats were individual platelet area (μm2),
percentage of platelet area, fibrin fiber area (μm2), per-
centage of fibrin fiber area, the ratio between the minor
and major axes, the ratio between the major and minor
axes of platelets, and the number of α-granules found
within each platelet (n = 100 platelets for each activating
substance).
For the dog samples, the intercellular area (μm2),
percentage of intercellular space, fibrin fiber area (μm2),
and percentage of fibrin fiber area were analyzed. This last
evaluation was performed in 30 fibrin fibers, including
those just over 0.5 mm in length, of which the width was
measured in the middle third of each fiber, perpendicular
to its central axis. The analyses were performed with a
magnification of 18,000 X. The measurements were made
with the digital analysis software Image J (Image Process-
ing and Analysis in Java, National Institutes of Health,
Maryland, USA).Data analysis
For all of the data, a Shapiro-Wilk normality test was
performed. The data from the digital analysis software
were compared using a Student’s t- test (t) for paired
samples, and the number of α-granules was compared
using the Wilcoxon test. The threshold for a statistically
significant difference was P ≤ 0.01 for all tests.
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